The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.75
Bid: 145.50
Ask: 150.00
Change: 0.00 (0.00%)
Spread: 4.50 (3.093%)
Open: 147.75
High: 147.75
Low: 147.75
Prev. Close: 147.75
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Santander UK Pass 2019 Bank of England Stress Test

16 Dec 2019 18:02

RNS Number : 0596X
Santander UK Group Holdings PLC
16 December 2019
 

 

16 December 2019

 

SANTANDER UK GROUP HOLDINGS PLC

 

SANTANDER UK PASSES THE 2019 BANK OF ENGLAND STRESS TEST

 

Santander UK notes the publication of the results of the 2019 stress tests conducted on seven major UK banks and building societies by the Bank of England. Santander UK has passed the stress test and, as a result of the exercise, the Bank of England does not require Santander UK to undertake any actions.

 

Since the introduction of IFRS 9 in January 2019, the stress test results are published on an IFRS 9 transitional and non-transitional basis, over a five-year stress period to the end of 2023.

 

Santander UK reported a CET 1 capital ratio of 13.9% as at 30 September 2019.

 

On an IFRS 9 transitional basis, Santander UK's lowest post-stress CRD IV end-point common equity tier 1 ('CET 1') capital ratio was modelled to be 9.5% before management actions and 10.8% after allowed management actions. On an IFRS 9 non-transitional basis, Santander UK's lowest post-stress CRD IV end-point CET 1 capital ratio was modelled to be 9.9% before management actions and 10.4% after allowed management actions.

 

These results are in excess of the CET 1 hurdle rate established by the Bank of England of 8.1% on an IFRS 9 transitional basis, and 7.3% on an IFRS 9 non-transitional basis.

 

The Bank of England's CET1 hurdle rate comprises the CRR Pillar 1 minimum of 4.5% together with a Pillar 2A CET1 requirement, an estimate of the applicable Systemic Risk Buffer and an adjustment to offset the pro-cyclical impacts of IFRS 9. Santander UK expects that a Pillar 2A requirement of 2.7% will be set in the first quarter of 2020.

 

On an IFRS 9 transitional basis Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2023, was modelled to be 3.2% before management actions and 3.8% after allowed management actions. On an IFRS 9 non-transitional basis Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2023, was modelled to be 3.3% before management actions and 3.7% after allowed management actions.

 

After allowed management actions, these results are in excess of the leverage threshold established by the Bank of England of 3.57% on an IFRS 9 transitional and 3.25% on an IFRS 9 non-transitional basis. Santander UK reported a leverage ratio of 4.6% as at 30 September 2019, up from 4.5% as at 31 December 2018. As at 30 September 2019 the leverage exposure was £274bn.  

 

 

 

 

Contacts

Bojana Flint

Director of Investor Relations & Strategic Initiatives

020 7756 6474

Adam Williams

Head of Media Relations

020 7756 5533

Disclaimer

Santander UK Group Holdings plc (Santander UK), Santander UK plc and Banco Santander caution that this announcement may contain forward-looking statements. Such forward-looking statements are found in various places throughout this announcement. Words such as "believes", "anticipates", "expects", "intends", "aims" and "plans" and other similar expressions are intended to identify forward-looking statements, but they are not the exclusive means of identifying such statements. Forward-looking statements include, without limitation, statements concerning our future business development and economic performance. These forward-looking statements are based on management's current expectations, estimates and projections and both Santander UK and Banco Santander caution that these statements are not guarantees of future performance. We also caution readers that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements. We have identified certain of these factors in the forward looking statements on page 243 of the Santander UK Group Holdings plc 2018 Annual Report. Investors and others should carefully consider the foregoing factors and other uncertainties and events. Undue reliance should not be placed on forward-looking statements when making decisions with respect to Santander UK, Santander UK plc, Banco Santander and/or their securities. Such forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update or revise any of them, whether as a result of new information, future events or otherwise. Statements as to historical performance, historical share price or financial accretion are not intended to mean that future performance, future share price or future earnings for any period will necessarily match or exceed those of any prior quarter.

Santander UK is a frequent issuer in the debt capital markets and regularly meets with investors via formal roadshows and other ad hoc meetings. In line with Santander UK's usual practice, over the coming quarter it expects to meet with investors globally to discuss this Quarterly Management Statement, the results contained herein and other matters relating to Santander UK.

 

Nothing in this announcement constitutes or should be construed as constituting a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCTFBPTMBMBBML
Date   Source Headline
22nd Jan 20184:58 pmRNSArticle 8
22nd Jan 20183:02 pmRNS1119 ISE Delisting announcement
16th Jan 20184:45 pmRNSPublication of Final Terms
11th Jan 201812:04 pmRNSPublication of Final Terms
3rd Jan 201811:25 amRNSArticle 8
27th Dec 20172:25 pmRNSNotice of Early Redemption
21st Dec 20171:15 pmRNSDirectorate Change
14th Dec 20177:47 amRNSXS1656513832 - 1116 Delisting
12th Dec 20179:00 amRNSXS1656513832 - 1116 ISE Delisting
11th Dec 20175:34 pmRNSArticle 8
8th Dec 20178:03 amRNSArticle 8
27th Nov 20175:14 pmRNSNotice of Early Redemption
27th Nov 201711:06 amRNSDirectorate Change
17th Nov 20174:23 pmRNSPublication of Final Terms
26th Oct 20173:12 pmRNSPublication of Suppl.Prospcts
26th Oct 20173:10 pmRNSPublication of Suppl.Prospcts
26th Oct 20177:15 amRNS3rd Quarter Results
23rd Oct 201712:03 pmRNSDelisting
16th Oct 20175:51 pmRNSNotice of Substitution of Issuer
16th Oct 20175:47 pmRNSNotice of Substitution of Issuer
16th Oct 20175:46 pmRNSNotice of Substitution of Issuer
16th Oct 20171:09 pmRNSRing-Fencing Update
13th Oct 20173:46 pmRNSPublication of Final Terms
27th Sep 20171:07 pmRNSPublication of Final Terms
20th Sep 201712:51 pmRNSPublication of Final Terms
19th Sep 20174:25 pmRNSPurchase & Cancellation of Notes
14th Sep 20176:32 pmRNSPublication of Suppl.Prospcts
14th Sep 20176:28 pmRNSPublication of Suppl.Prospcts
14th Sep 20177:15 amRNSHalf-year Report
14th Sep 20177:15 amRNSHalf-year Report
12th Sep 201711:53 amRNSNotice of Delisting XS1606968771
1st Sep 20173:10 pmRNSPublication of Final Terms
31st Aug 20177:00 amRNSPublication of a Prospectus
31st Aug 20177:00 amRNSPublication of a Prospectus
28th Jul 20174:52 pmRNSGlobal Covered Bond Programme Supplement
28th Jul 20174:50 pmRNSMedium Term Note Programme Supplement
28th Jul 20177:15 amRNSQMS for 6 months ending 30 June 2017
14th Jul 20172:05 pmRNSNotice of Delisting
2nd Jun 20175:47 pmRNSPublication of a Prospectus
22nd May 201710:52 amRNSDirectorate Change
19th May 20172:12 pmRNSNotice of Delisting XS1561800175
18th May 201711:02 amRNSPublication of Final Terms
4th May 20174:17 pmRNSPublication of Final Terms
26th Apr 20176:27 pmRNSPublication of Suppl.Prospcts
26th Apr 20175:58 pmRNSPublication of Suppl.Prospcts
26th Apr 20177:30 amRNS1st Quarter Results
6th Apr 20176:30 pmRNSPublication of a Prospectus
31st Mar 20172:45 pmRNSResult of AGM
10th Mar 201711:56 amRNSPublication of Final Terms
23rd Feb 20175:40 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.